Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study
Authors:
- 23 May 2022
- journal article
- Published by Elsevier in Metabolism
- Vol. 133, 155220
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Stroke geneticsHuman Molecular Genetics, 2011
- Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen: reversal by aerobic exerciseThe Journal of Physiology, 2010
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE studyJournal Of Hypertension, 2010
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessJACC, 2010
- Insulin resistance, inflammation, and non-alcoholic fatty liver diseaseTrends in Endocrinology & Metabolism, 2008
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Arterial stiffness: clinical relevance, measurement and treatmentClinical Science, 2007
- Contour analysis of the photoplethysmographic pulse measured at the fingerJournal Of Hypertension, 2006
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993